On November 10, 2020 BiomX Inc. (NYSE American: PHGE), a clinical stage company developing natural and engineered phage therapies targeting specific pathogenic bacteria, reported that Jonathan Solomon, Chief Executive Officer, will participate in the following upcoming investor conferences (Press release, BiomX, NOV 10, 2020, View Source [SID1234570556]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Event: H.C. Wainwright 6th Annual Israel Conference (Virtual)
Date: Thursday, Nov. 12, 2020
Time: 9:30 a.m. EST
Webcast link: BiomX HCW Israel Conference Live Link and Playback
Event: Jefferies 2020 Virtual London Healthcare Conference
Date: Thursday, Nov. 19, 2020
Time: 12:00 p.m. EST
Webcast link: BiomX Jefferies London HC Conference Live Link and Playback.
Both live and archived webcasts will also be available in the Events section of the BiomX website at www.biomx.com.